Prometheus Bio Inc.

medical devices

About

Located in Hangzhou, China, Prometheus is committed to a true partnership with customers by providing fast, high-quality and accurate diagnostics products and services. Prometheus is owned by CPC Group, which is a global leader in peptide industry. Focusing on technology, innovation and quality control, our manufacturing covers a broad range of areas: Drug Test Series; Women's Health Series; Cardiac Markers Series; Infectious Diseases Series and Tumor Markers Series. Due to strict quality standards, outstanding product design and one-stop shop services, Prometheus is currently the preferred vendor for many customers at home and overseas. Prometheus' plant was granted ISO 9001:2008 & ISO13485:2003 certification. In November 2012, Prometheus' production facility was inspected by US FDA and no 483 form was issued. High standards and compliance, to which Prometheus faithfully adheres, allowing our customers to have the utmost confidence in the validity of their project.

Technologies

Mobile FriendlyAddThisGoogle Font APIApache

Keywords

in vitro diagnosticsdrug of abusecardiac markerswomens healthtumor markersinfectious diseasesmedical equipment manufacturingrapid diagnostic testsinfectious disease diagnosticsdrug of abuse testspoct platformsautomated test devicespoint of care testingdiagnostic platformsdrug screeningsaliva drug testsimmunofluorescence platformb2bfecal occult blood testsfluorescence immunityurine drug testsce marked testshealthcaregovernmentinfectious disease testsfda approvedfeline and canine rapid testsmonkeypox virus testskidney function testsvector borne pathogens

Location

Hangzhou, China, 310018

Related Companies

Companies in the same industry